Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue for prevention of vasoplegic syndrome in cardiac surgery
RBR-96ch27cPhase 3Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methylene blue in Vasoplegia (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Postoperative vasoplegic syndrome prevention. Started Aug 2021; status: recruiting.
02
Drugs
methylene blue
03
Conditions
Vasoplegia
Beyond the preview
Go deeper on RBR-96ch27c.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-96ch27c.